Thirty-five days post-tumor cell inoculation, when the average bioluminescence intensity (BLI) of the tumors reached 5 × 109, mice were randomized and infused with mock T cells and CT3 CAR T cells at various doses, including 2.5 million (2.5M), 5M, and 10M. The gene discussed is CAGE1; the disease is neoplasm.